APA (7th ed.) Citation

He, R., Li, L., Liu, L., Ma, Y., Fan, S., Liu, L., . . . Xian, X. (2023). Ceftriaxone improves impairments in synaptic plasticity and cognitive behavior in APP/PS1 mouse model of Alzheimer's disease by inhibiting extrasynaptic NMDAR‐STEP61 signaling. Journal of neurochemistry, 166(2), 215-232. https://doi.org/10.1111/jnc.15874

Chicago Style (17th ed.) Citation

He, Ruo‐Bing, Li Li, Li‐Zhe Liu, Ya‐Jun Ma, Shu‐Juan Fan, Li‐Rong Liu, Wen‐Bin Li, and Xiao‐Hui Xian. "Ceftriaxone Improves Impairments in Synaptic Plasticity and Cognitive Behavior in APP/PS1 Mouse Model of Alzheimer's Disease by Inhibiting Extrasynaptic NMDAR‐STEP61 Signaling." Journal of Neurochemistry 166, no. 2 (2023): 215-232. https://doi.org/10.1111/jnc.15874.

MLA (9th ed.) Citation

He, Ruo‐Bing, et al. "Ceftriaxone Improves Impairments in Synaptic Plasticity and Cognitive Behavior in APP/PS1 Mouse Model of Alzheimer's Disease by Inhibiting Extrasynaptic NMDAR‐STEP61 Signaling." Journal of Neurochemistry, vol. 166, no. 2, 2023, pp. 215-232, https://doi.org/10.1111/jnc.15874.